Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by Plato5on Apr 05, 2010 4:49pm
641 Views
Post# 16958136

RE: Re Being informed.........

RE: Re Being informed.........Isaloser - not sure why you asked those questions. But, I think the observations about perceptions are quite valid and useful. But we all need to be wary also of perception manipulation and I think many of the folks on this board are quite clever in reading between the lines, etc.

I said in an earlier post that "If voclosporin works ... " Please understand that was not intended as a clinical statment about the drug's efficacy. I know as well as anyone here the results of the trials and it is based on those that I have supported the company. But as an investor it will be important that the drug gets properly marketed, priced and promoted. Then it will start to work for us in a fiscal sense. Of course there is always the possibility that we could hit snags in the approval process or that some unforseen side effect emerges with wider testing, etc. There are always "ifs" in this game. But, I am personally sold on and optimistac that the drug will work for us.

As far as researchers being bad at extracting shareholder value - agreed!
<< Previous
Bullboard Posts
Next >>